Objective:This study was designed to find out the active components of Ranunculi Ternati Radix using network pharmacology,and to explore its potential target and pharmacological mechanism.Methods:By the TCMSP database...Objective:This study was designed to find out the active components of Ranunculi Ternati Radix using network pharmacology,and to explore its potential target and pharmacological mechanism.Methods:By the TCMSP database,combined with oral bioavailability(≥30%)analysis and resistance(≥0.18),screening of active ingredients in Ranunculus ternatus Thunb.Retrieve the protein targets of the compounds from the TCMSP database.Associated Proteins and Gene Names were received via UniProt database.The protein interaction network was constructed by applying String database and Cytoscape software.Gene Ontology and Pathway Enrichment Analysis were developed on the basis of DAVID database.Results:10 active compounds including beta-sitosterol,campesterol,Mandenol were selected from Ranunculi Ternati Radix.And it produced its effects on different diseases mainly by regulating targets including PIK3CG,HSP90AA1,BAX and BCL2,which involved signaling pathways containing Pathways in cancer、PI3K-Akt signaling pathway、Hepatitis B、Tuberculosis and so on.Some published papers had confirmed by each other.Meanwhile,this work predics that Ranunculi Ternati Radix had the potential to treat non-alcoholic fatty liver disease.Conclusion:This study preliminarily validated the major targets and pathways of Ranunculi Ternati Radix acting on different diseases,which laid a foundation for further study on its mechanisms.展开更多
Objective:To explore the molecular biological mechanism of the"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer based on network pharmacology.Methods:Searching the TCMSP...Objective:To explore the molecular biological mechanism of the"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer based on network pharmacology.Methods:Searching the TCMSP database and previous literatures to screen the active compounds which resist lung cancer activity in salvia chinensis and radix ranunculi ternati.The candidate compounds were unified in the DrugBank to find the corresponding drug targets which were corrected to the standard gene names by the UniProt database.The Swiss Target Prediction platform was used to predict other targets.Searching GeneCards,OMIM and DrugBank to obtain genes related to lung cancer.After taking the intersection,the candidate gene target of drug pair in the treatment of lung cancer could be obtained.The"herbs-compounds-targets-disease"network was bulit with Cytoscape,and the PPI network was bulit on the STRING platform while the core network nodes were screened.GO and KEGG analysis on candidate genes was implemented through Metacape platform,and a"pathways-targets"network was bulit to further screen key genes.Results:A total of 16 active compounds in salvia chinensis,18 active compounds in radix ranunculi ternati,164 candidate targets,2443 GO functions and 170 KEGG pathways was obtained.Conclusion:The effective compounds of"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer are quercetin,ursolic acid,β-sitosterol and caffeic acid.The key targets are MAPK1,AKT1,PIK3R1,RAF1 and EGFR.GO functions mainly include cytokines,oxidative stress,plasma membrane transmission,protein kinase binding and activity,apoptosis.KEGG could directly regulate pathways in cancer,non-small cells lung cancer pathway and small cell lung cancer pathway.KEGG also involves EGFR tyrosine kinase inhibitor resistance,IL-17,TNF,PI3K-AKT signaling pathway and apoptosis.This study reveals the molecular biological mechanism of"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer.It is reasoned that its potential targets affect multiple signaling pathways and ultimately resist the proliferation,differentiation,invasion,metastasis and promote apoptosis of lung cancer cells.Evidence for further experimental study is provided by this study.展开更多
为了考察影响猫爪草综合提取工艺的各因素,确定猫爪草综合提取最佳工艺条件,在前期单因素考察的基础上,以浸提温度、超声频率、超声时间和固液比为考察因素,以猫爪草干膏率和多糖提取率为考察指标,采用正交试验设计考察猫爪草最佳提取...为了考察影响猫爪草综合提取工艺的各因素,确定猫爪草综合提取最佳工艺条件,在前期单因素考察的基础上,以浸提温度、超声频率、超声时间和固液比为考察因素,以猫爪草干膏率和多糖提取率为考察指标,采用正交试验设计考察猫爪草最佳提取工艺。结果表明,猫爪草最佳提取工艺为浸提温度50℃,超声频率40 k Hz,每次超声20 min,固液比1∶30。在此条件下,猫爪草干膏率为38.90%,多糖提取率为32.71%。展开更多
基金National Science Foundation of China(No.81973815)Natural Sci ence Foundation of Guangdong Province(No.2017A030313886)
文摘Objective:This study was designed to find out the active components of Ranunculi Ternati Radix using network pharmacology,and to explore its potential target and pharmacological mechanism.Methods:By the TCMSP database,combined with oral bioavailability(≥30%)analysis and resistance(≥0.18),screening of active ingredients in Ranunculus ternatus Thunb.Retrieve the protein targets of the compounds from the TCMSP database.Associated Proteins and Gene Names were received via UniProt database.The protein interaction network was constructed by applying String database and Cytoscape software.Gene Ontology and Pathway Enrichment Analysis were developed on the basis of DAVID database.Results:10 active compounds including beta-sitosterol,campesterol,Mandenol were selected from Ranunculi Ternati Radix.And it produced its effects on different diseases mainly by regulating targets including PIK3CG,HSP90AA1,BAX and BCL2,which involved signaling pathways containing Pathways in cancer、PI3K-Akt signaling pathway、Hepatitis B、Tuberculosis and so on.Some published papers had confirmed by each other.Meanwhile,this work predics that Ranunculi Ternati Radix had the potential to treat non-alcoholic fatty liver disease.Conclusion:This study preliminarily validated the major targets and pathways of Ranunculi Ternati Radix acting on different diseases,which laid a foundation for further study on its mechanisms.
基金National Natural Science Foundation of China(No.1673961)Beijing Natural Science Foundation Project(No.7172186)Special Training Program for Outstanding Young Scientific and Technological Talents(innovation)of Chinese Academy of Traditional Chinese Medicine(No.ZZ13-YQ-028)。
文摘Objective:To explore the molecular biological mechanism of the"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer based on network pharmacology.Methods:Searching the TCMSP database and previous literatures to screen the active compounds which resist lung cancer activity in salvia chinensis and radix ranunculi ternati.The candidate compounds were unified in the DrugBank to find the corresponding drug targets which were corrected to the standard gene names by the UniProt database.The Swiss Target Prediction platform was used to predict other targets.Searching GeneCards,OMIM and DrugBank to obtain genes related to lung cancer.After taking the intersection,the candidate gene target of drug pair in the treatment of lung cancer could be obtained.The"herbs-compounds-targets-disease"network was bulit with Cytoscape,and the PPI network was bulit on the STRING platform while the core network nodes were screened.GO and KEGG analysis on candidate genes was implemented through Metacape platform,and a"pathways-targets"network was bulit to further screen key genes.Results:A total of 16 active compounds in salvia chinensis,18 active compounds in radix ranunculi ternati,164 candidate targets,2443 GO functions and 170 KEGG pathways was obtained.Conclusion:The effective compounds of"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer are quercetin,ursolic acid,β-sitosterol and caffeic acid.The key targets are MAPK1,AKT1,PIK3R1,RAF1 and EGFR.GO functions mainly include cytokines,oxidative stress,plasma membrane transmission,protein kinase binding and activity,apoptosis.KEGG could directly regulate pathways in cancer,non-small cells lung cancer pathway and small cell lung cancer pathway.KEGG also involves EGFR tyrosine kinase inhibitor resistance,IL-17,TNF,PI3K-AKT signaling pathway and apoptosis.This study reveals the molecular biological mechanism of"salvia chinensis and radix ranunculi ternati"drug pair in the treatment of lung cancer.It is reasoned that its potential targets affect multiple signaling pathways and ultimately resist the proliferation,differentiation,invasion,metastasis and promote apoptosis of lung cancer cells.Evidence for further experimental study is provided by this study.
文摘为了考察影响猫爪草综合提取工艺的各因素,确定猫爪草综合提取最佳工艺条件,在前期单因素考察的基础上,以浸提温度、超声频率、超声时间和固液比为考察因素,以猫爪草干膏率和多糖提取率为考察指标,采用正交试验设计考察猫爪草最佳提取工艺。结果表明,猫爪草最佳提取工艺为浸提温度50℃,超声频率40 k Hz,每次超声20 min,固液比1∶30。在此条件下,猫爪草干膏率为38.90%,多糖提取率为32.71%。
